In 1995 was created Foundation for Technological Innovation (FIT), which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in Switzerland. The main department of described Corporate Investor is located in the Lausanne.
Comparing to the other companies, this Foundation for Technological Innovation (FIT) performs on 20 percentage points less the average number of lead investments. Considering the real fund results, this Corporate Investor is 79 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The increased amount of exits for fund were in 2019. The fund is constantly included in 7-12 deals per year.
The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Electronics, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Nexthink, Kandou Bus, SOPHiA GENETICS. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Foundation for Technological Innovation (FIT), startups are often financed by investiere | Verve Capital Partners, Polytech Ventures, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Venture Kick, EASME - EU Executive Agency for SMEs. In the next rounds fund is usually obtained by Swisscom Ventures, VI Partners AG, MassChallenge.
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Maven Health | $383K | 09 Jan 2024 | Lausanne, Vaud, Switzerland | ||
Algorized | $720K | 01 Nov 2023 | Geneve, Vaud, Switzerland | ||
ClearSky | $152K | 15 Sep 2023 | Geneve, Vaud, Switzerland | ||
PeriVision | 24 Jul 2023 | Bern, Bern, Switzerland | |||
Voltiris | $1M | 21 Dec 2022 | Lausanne, Vaud, Switzerland | ||
Flybotix | $1M | 15 Apr 2021 | Lausanne, Vaud, Switzerland | ||
Alogo Analysis | $545K | 16 Jun 2020 | Hautemorges, Vaud, Switzerland | ||
RatioX | $109K | 01 Dec 2019 | Lausanne, Vaud, Switzerland | ||
Lumendo | $109K | 03 Oct 2019 | Vaud, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Maven Health | $383K | 09 Jan 2024 | Lausanne, Vaud, Switzerland | ||
Algorized | $720K | 01 Nov 2023 | Geneve, Vaud, Switzerland | ||
ClearSky | $152K | 15 Sep 2023 | Geneve, Vaud, Switzerland | ||
PeriVision | 24 Jul 2023 | Bern, Bern, Switzerland | |||
Voltiris | $1M | 21 Dec 2022 | Lausanne, Vaud, Switzerland | ||
Flybotix | $1M | 15 Apr 2021 | Lausanne, Vaud, Switzerland | ||
Alogo Analysis | $545K | 16 Jun 2020 | Hautemorges, Vaud, Switzerland | ||
RatioX | $109K | 01 Dec 2019 | Lausanne, Vaud, Switzerland | ||
Lumendo | $109K | 03 Oct 2019 | Vaud, Switzerland |